Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
940
NCT01479244
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
Phase: Phase 3
Role: Lead Sponsor
Start: Nov 30, 2011
Completion: Sep 21, 2016
NCT01936636
Observational Registry Study of Quality of Life When Treating BTcP With Abstral
Phase: N/A
Start: Oct 31, 2013
Completion: Jun 30, 2015
NCT02125318
A Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders
Phase: Phase 2
Start: May 31, 2014
Completion: May 31, 2016